p.86 抽出テキスト

98. Juraschek SP, Cortez MM, Flack JM, Ghazi L, Kenny RA, Rahman M, et al. Orthostatic hypotension in adults with hypertension: a scientific statement from the American Heart Association. Hypertension 2024;81:e16–30. https://doi.org/10.1161/hyp. 0000000000000236 99. Raber I, Belanger MJ, Farahmand R, Aggarwal R, Chiu N, Al Rifai M, et al. Orthostatic hypotension in hypertensive adults: Harry Goldblatt award for early career investigators 2021. Hypertension 2022;79:2388–96. https://doi.org/10.1161/hypertensionaha. 122.18557 100. Wieling W, Kaufmann H, Claydon VE, van Wijnen VK, Harms MPM, Juraschek SP, et al. Diagnosis and treatment of orthostatic hypotension. Lancet Neurol 2022;21:735–46. https://doi.org/10.1016/s1474-4422(22)00169-7 101. Juraschek SP, Daya N, Rawlings AM, Appel LJ, Miller ER, Windham BG, et al. Association of history of dizziness and long-term adverse outcomes with early vs later orthostatic hypotension assessment times in middle-aged adults. JAMA Intern Med 2017;177:1316–23. https://doi.org/10.1001/jamainternmed.2017.2937 102. Brignole M, Moya A, de Lange FJ, Deharo J-C, Elliott PM, Fanciulli A, et al. Practical instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J 2018;39:e43–80. https://doi.org/10.1093/eurheartj/ehy071 103. Rivasi G, Groppelli A, Brignole M, Soranna D, Zambon A, Bilo G, et al. Association between hypotension during 24 h ambulatory blood pressure monitoring and reflex syncope: the SynABPM 1 study. Eur Heart J 2022;43:3765–76. https://doi.org/10.1093/ eurheartj/ehac347 104. Smith TO, Sillito JA, Goh CH, Abdel-Fattah A-R, Einarsson A, Soiza RL, et al. Association between different methods of assessing blood pressure variability and incident cardiovascular disease, cardiovascular mortality and all-cause mortality: a systematic review. Age Ageing 2020;49:184–92. https://doi.org/10.1093/ ageing/afz178 105. Kim S, Xiao X, Chen J. Advances in photoplethysmography for personalized cardiovascular monitoring. Biosensors (Basel) 2022;12:863. https://doi.org/10.3390/bios12100863 106. Dagamseh A, Qananwah Q, Al Quran H, Shaker Ibrahim K. Towards a portable-noninvasive blood pressure monitoring system utilizing the photoplethysmogram signal. Biomed Opt Express 2021;12:7732–51. https://doi.org/10.1364/boe.444535 107. Sharman JE, Avolio AP, Baulmann J, Benetos A, Blacher J, Blizzard CL, et al. Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization. Eur Heart J 2017;38:2805–12. https://doi. org/10.1093/eurheartj/ehw632 108. Sharman JE, O’Brien E, Alpert B, Schutte AE, Delles C, Hecht Olsen M, et al. Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure. J Hypertens 2020; 38:21–9. https://doi.org/10.1097/hjh.0000000000002246 109. Lunardi M, Muhammad F, Shahzad A, Nadeem A, Combe L, Simpkin AJ, et al. Performance of wearable watch-type home blood pressure measurement devices in a real-world clinical sample. Clin Res Cardiol. 2023. https://doi.org/10.1007/s00392- 023-02353-7 110. Clark CE, Warren FC, Boddy K, McDonagh STJ, Moore SF, Teresa Alzamora M, et al. Higher arm versus lower arm systolic blood pressure and cardiovascular outcomes: a meta-analysis of individual participant data from the INTERPRESS-IPD collaboration. Hypertension 2022;79:2328–35. https://doi.org/10.1161/hypertensionaha.121.18921 111. Margolis KL, Dehmer SP, Sperl-Hillen J, O’Connor PJ, Asche SE, Bergdall AR, et al. Cardiovascular events and costs with home blood pressure telemonitoring and pharmacist management for uncontrolled hypertension. Hypertension 2020;76: 1097–103. https://doi.org/10.1161/hypertensionaha.120.15492 112. Sheppard JP, Tucker KL, Davison WJ, Stevens R, Aekplakorn W, Bosworth H B, et al. Self-monitoring of blood pressure in patients with hypertension-related multimorbidity: systematic review and individual patient data meta-analysis. Am J Hypertens 2020;33:243–51. https://doi.org/10.1093/ajh/hpz182 113. Cooke G, Doust J, Sanders S. Is pulse palpation helpful in detecting atrial fibrillation? A systematic review. J Fam Pract 2006;55:130–4. 114. Arvanitis M, Qi G, Bhatt DL, Post WS, Chatterjee N, Battle A, et al. Linear and nonlinear Mendelian randomization analyses of the association between diastolic blood pressure and cardiovascular events: the J-curve revisited. Circulation 2021;143: 895–906. https://doi.org/10.1161/circulationaha.120.049819 115. Whelton SP, McEvoy JW, Shaw L, Psaty BM, Lima JAC, Budoff M, et al. Association of normal systolic blood pressure level with cardiovascular disease in the absence of risk factors. JAMA Cardiol 2020;5:1011–8. https://doi.org/10.1001/jamacardio.2020.1731 116. Rahimi K, Bidel Z, Nazarzadeh M, Copland E, Canoy D, Ramakrishnan R, et al. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet 2021;397:1625–36. https://doi.org/10. 1016/S0140-6736(21)00590-0 117. Ji H, Niiranen TJ, Rader F, Henglin M, Kim A, Ebinger JE, et al. Sex differences in blood pressure associations with cardiovascular outcomes. Circulation 2021;143:761–3. https://doi.org/10.1161/circulationaha.120.049360 118. Kringeland E, Tell GS, Midtbø H, Igland J, Haugsgjerd TR, Gerdts E. Stage 1 hypertension, sex, and acute coronary syndromes during midlife: the Hordaland health study. Eur J Prev Cardiol 2022;29:147–54. https://doi.org/10.1093/eurjpc/zwab068 119. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group. N Engl J Med 1997;336:1117–24. https://doi.org/10.1056/nejm199704173361601 120. Toledo E, Hu FB, Estruch R, Buil-Cosiales P, Corella D, Salas-Salvadó J, et al. Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomized controlled trial. BMC Med 2013;11:207. https://doi.org/10.1186/1741-7015- 11-207 121. Sundström J, Arima H, Jackson R, Turnbull F, Rahimi K, Chalmers J, et al. Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. Ann Intern Med 2015;162:184–91. https://doi.org/10.7326/m14-0773 122. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387:957–67. https://doi.org/10.1016/s0140- 6736(15)01225-8 123. Muntner P, Whelton PK. Using predicted cardiovascular disease risk in conjunction with blood pressure to guide antihypertensive medication treatment. J Am Coll Cardiol 2017;69:2446–56. https://doi.org/10.1016/j.jacc.2017.02.066 124. Herrett E, Strongman H, Gadd S, Tomlinson L, Nitsch D, Bhaskaran K, et al. The importance of blood pressure thresholds versus predicted cardiovascular risk on subsequent rates of cardiovascular disease: a cohort study in English primary care. Lancet Healthy Longev 2022;3:e22–30. https://doi.org/10.1016/s2666-7568(21)00281-6 125. Navar AM, Pencina MJ, Peterson ED. Assessing cardiovascular risk to guide hypertension diagnosis and treatment. JAMA Cardiol 2016;1:864–71. https://doi.org/10.1001/ jamacardio.2016.2861 126. Kovell LC, Ahmed HM, Misra S, Whelton SP, Prokopowicz GP, Blumenthal RS, et al. US hypertension management guidelines: a review of the recent past and recommendations for the future. J Am Heart Assoc 2015;4:e002315. https://doi.org/10.1161/jaha. 115.002315 127. McEvoy JW, Martin SS, Dardari ZA, Miedema MD, Sandfort V, Yeboah J, et al. Coronary artery calcium to guide a personalized risk-based approach to initiation and intensification of antihypertensive therapy. Circulation 2017;135:153–65. https:// doi.org/10.1161/circulationaha.116.025471 128. Rossello X, Dorresteijn JA, Janssen A, Lambrinou E, Scherrenberg M, Bonnefoy-Cudraz E, et al. Risk prediction tools in cardiovascular disease prevention: a report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). Eur J Prev Cardiol 2019;26:1534–44. https://doi.org/10.1177/2047487319846715 129. Ioannidis JPA. Diagnosis and treatment of hypertension in the 2017 ACC/AHA guidelines and in the real world. JAMA 2018;319:115–6. https://doi.org/10.1001/ jama.2017.19672 130. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation 2018;138:e484–594. https://doi.org/ 10.1161/cir.0000000000000596 131. Rahimi K, Bidel Z, Nazarzadeh M, Copland E, Canoy D, Wamil M, et al. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis. Lancet 2021;398:1053–64. https://doi.org/ 10.1016/S0140-6736(21)01921-8 132. Brunström M, Carlberg B. Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Intern Med 2018;178:28–36. https://doi.org/10.1001/ jamainternmed.2017.6015 133. Arguedas JA, Leiva V, Wright JM. Blood pressure targets in adults with hypertension. Cochrane Database Syst Rev 2020;12:CD004349. https://doi.org/10.1002/14651858. CD004349.pub3 134. Saiz LC, Gorricho J, Garjón J, Celaya MC, Erviti J, Leache L. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. Cochrane Database Syst Rev 2022;11:CD010315. https://doi.org/10.1002/14651858.CD010315. pub5 135. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373:2103–16. https://doi.org/10.1056/NEJMoa1511939 136. Zhang W, Zhang S, Deng Y, Wu S, Ren J, Sun G, et al. Trial of intensive blood-pressure control in older patients with hypertension. N Engl J Med 2021;385:1268–79. https:// doi.org/10.1056/NEJMoa2111437 137. Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;362:1575–85. https://doi.org/10.1056/NEJMoa1001286 138. Ferrucci L, Furberg CD, Penninx BW, DiBari M, Williamson JD, Guralnik JM, et al. Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. Circulation 2001;104:1923–6. https://doi.org/10.1161/hc4101.097520

ESC Guidelines                                                                                                                                                                                          3997

Downloaded from academic.oup.com/eurheartj/article/45/38/3912/7741010 by guest on 07 October 2026